Case number 3:25-cv-00230
ASTRAZENECA PHARMACEUTICALS LP et al v. NATCO PHARMA LIMITED > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 6, 2025 | 17 | LETTER ORDER that the Court finds that the new lawsuits shall be consolidated with 23-cv-796. The Court further finds that the parties' shall disclose their contentions in the standard order outlined in L.Pat.R. 3.6 according to the enclosed schedule. Cases associated. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/6/2025. (mlh) (Entered: 06/06/2025) (2) |
| Jun 6, 2025 | N/A | ***Civil Case Terminated. (mlh) (Entered: 06/06/2025) (0) |
| Apr 15, 2025 | 16 | ANSWER to Counterclaim by ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH.(CHEVALIER, CHARLES) (Entered: 04/15/2025) (9) |
| Mar 13, 2025 | 15 | Application and Proposed Order for Clerk's Order to extend time to answer. (CHEVALIER, CHARLES) (Entered: 03/13/2025) (2) |
| Mar 13, 2025 | N/A | Clerk`s Text Order - The document 15 Application for Clerk's Order to Ext Answer/Proposed Order submitted by ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, and MSD INTERNATIONAL BUSINESS GMBH has been GRANTED. The answer due date has been set for 4/15/2025. (mlh) (Entered: 03/13/2025) (0) |
| Mar 11, 2025 | 13 | ANSWER to Complaint , Separate Defenses and, COUNTERCLAIM against ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH by NATCO PHARMA LIMITED.(RICHTER, JAMES) (Entered: 03/11/2025) (30) |
| Mar 11, 2025 | 14 | Corporate Disclosure Statement by NATCO PHARMA LIMITED. (RICHTER, JAMES) (Entered: 03/11/2025) (2) |
| Jan 23, 2025 | 12 | STIPULATION AND ORDER of dismissal as to NATCO PHARMA INC., without prejudice. Signed by Judge Robert Kirsch on 1/23/2025. (kht) (Entered: 01/23/2025) (4) |
| Jan 22, 2025 | 10 | NOTICE of Appearance by JAMES S. RICHTER on behalf of NATCO PHARMA LIMITED, NATCO PHARMA INC. (RICHTER, JAMES) (Entered: 01/22/2025) (1) |
| Jan 22, 2025 | 11 | Letter from Defendants to the Honorable Robert Kirsch, USDJ re Dismissal of Natco Pharma Inc.. (Attachments: # 1 Text of Proposed Order and Stipulation)(RICHTER, JAMES) (Entered: 01/22/2025) (0) |
| Jan 16, 2025 | 9 | WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. NATCO PHARMA LIMITED waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/16/2025) (1) |
| Jan 10, 2025 | 7 | AO120 Patent/Trademark Form filed. (dmr3) (Main Document 7 replaced on 1/10/2025) (dmr3, ). (Entered: 01/10/2025) (1) |
| Jan 10, 2025 | 8 | SUMMONS ISSUED as to NATCO PHARMA INC., NATCO PHARMA LIMITED. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/10/2025) (2) |
| Jan 9, 2025 | 1 | Complaint* (1) |
| Jan 9, 2025 | 2 | Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2) |
| Jan 9, 2025 | 3 | Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2) |
| Jan 9, 2025 | 4 | Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2) |
| Jan 9, 2025 | 5 | Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2) |
| Jan 9, 2025 | 6 | Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2) |
| Jan 9, 2025 | N/A | Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (dmr3) (Entered: 01/10/2025) (0) |
